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Abstract
Panic disorder (PD) is associated with increased body vigilance 
and reduced cognitive resources directed at non-fear-related 
stimuli, particularly in the absence of stimulus-rich environ-
ments. To date, only few studies have investigated whether this 
deficit in PD is reflected in reduced mismatch negativity (MMN), 
an event-related potential indexing preattentive sensitivity to 
unexpected stimulus changes. We tested 35 patients affected 
by PD and 42 matched healthy controls in an oddball para-
digm, using frequency and duration deviant stimuli to measure 
auditory MMN. PD patients displayed reduced duration MMN 
amplitudes in comparison to healthy controls. No group differ-
ences were detected for duration MMN latency, as well as fre-
quency MMN indices. Results support the notion of reduced 
processing of non-fear-related stimuli in PD patients, particu-
larly with regard to the preattentive processing of sound dura-
tion deviants. Additionally, our findings are in line with clinical 
studies reporting divergent deficits in preattentive processing 
of frequency and duration deviants. © 2019 S. Karger AG, Basel
Introduction
Panic disorder (PD) is a condition characterized by 
recurrent panic attacks, worry about their further occur-
rences and avoidance behaviors [1]. Its lifetime preva-
lence is estimated to range between 3 and 4% [2]. It is as-
sociated with both significant impairment in quality of 
life [3, 4] and substantial financial cost [5].
On a cognitive level, PD is associated with abnormalities 
in attention control and information processing. In gen-





eral, evidence shows that PD patients preferentially direct 
their attention to threat-related stimuli such as body per-
ceptions or panic-related stimuli (such as crowds). In con-
trast to these threat-related stimuli, PD patients have been 
shown to process their environment to a reduced extent 
[6–9]. This attentional bias is assumed to lead to a pro-
nounced perception of early panic symptoms which in 
turn leads to increased alertness and thereby further inten-
sifies panic attacks [10]. Additionally, this attentional bias 
seems to maintain PD as increased body vigilance predicts 
the future occurrence of panic attacks [11] and because it 
has been shown that increased awareness of body symp-
toms in PD is associated with a higher reactivity to sudden 
fear-inducing environmental stimuli [12].
It needs to be noted however that abnormalities in infor-
mation processing in PD cannot be simplified as increased 
processing of body and anxiety symptoms while showing 
reduced processing of environmental non-fear-related 
stimuli. In particular, studies have reported deficits in PD to 
ignore monotonous serial stimuli [13] or stimuli of low rel-
evance [12, 14–16]. Hence, it is more accurate to assume that 
PD patients show deficits in adequately assessing the mean-
ing of stimuli, that is differentiating signal from noise [17], 
and therefore misdirect information-processing resources.
Neuropsychological studies of event-related potentials 
(ERP) support this notion of abnormal information pro-
cessing in PD, although it needs to be noted that findings 
are at times mixed. For instance, one branch of ERP studies 
investigated N1. This amplitude is observed in early atten-
tive information processes and declines when stimuli are 
repeatedly displayed [18, 19]. There is evidence for in-
creased N1 in PD [20–23], though some studies did report 
equal N1 amplitudes between PD patients and healthy con-
trols (HC) [24, 25]. Further abnormalities in information 
processing in PD have been reported for increased P3a am-
plitudes to rare stimuli in a common two-tone oddball task, 
most likely indicating irregularities in passive attention 
processes [24]. In addition, reduced P3 amplitudes have 
been reported, equally hinting at deviations in active atten-
tion processes [26]. Additionally, there is evidence for in-
creased error-related negativity in PD patients which sug-
gests a tendency for increased processing of internal signals 
after committing errors [27]. Taken together, there is sub-
stantial neuropsychological evidence for information-pro-
cessing abnormalities in PD.
One possibility to further elucidate abnormalities in the 
processing of non-fear-related stimuli in PD is the mis-
match negativity (MMN). MMN is an ERP that commonly 
peaks between 150 and 250 ms after an unexpected stimulus 
change. The MMN is defined as the difference wave calcu-
lated by subtracting the ERP to standard stimuli from the 
ERP to deviant stimuli. Its latency becomes shorter when 
stimuli changes are more salient [28, 29]. As the MMN can 
be detected even when the stimuli are not consciously at-
tended to, it is interpreted as a preattentive cognitive pro-
cess indexing the accuracy in detecting changes [30]. Tra-
ditionally, the MMN has been studied with electroencepha-
lography (EEG) for simple auditory stimuli. A very common 
experimental paradigm is the passive oddball paradigm. It 
consists in the presentation of standard stimuli and less fre-
quent stimuli that differ in certain characteristics such as 
length or frequency from the standard stimuli. However, a 
considerable amount of research has replicated MMN 
across different modalities [e.g., visual stimuli 31], increas-
ingly complex stimulus configurations [for instance gram-
mar violations, 32] and various methodologies [such as 
functional magnetic resonance imaging, 33]. These varying 
replications suggest that MMN represents a universally im-
portant preattentive cognitive process that applies to detec-
tion of changes across various modalities.
MMN has been used with increasing interest in order 
to elucidate the neurocognitive underpinnings of distinct 
clinical conditions [34]. Most prominently, evidence for 
the association of cognitive deficits with reduced MMN 
amplitudes has been found in dyslexia [35], schizophre-
nia [36–40], depression [41] and Alzheimer’s disease 
[42]. To date, relatively few studies have investigated 
MMN in PD. To our knowledge, only two trials available 
in English addressed this topic in small samples of up to 
15 patients with PD [43, 44], yielding contrasting results. 
Tang et al. [44] found decreased MMN amplitudes by us-
ing a visual paradigm, one other study applying auditory 
stimuli reported increased intensity MMN but normal 
frequency and duration MMN amplitudes in this condi-
tion [43].
Hence, the present study sought to clarify the charac-
teristics of MMN in PD within a relatively large sample of 
patients. We hypothesized abnormalities in MMN in PD 
as compared to HC. As evidence to date on MMN in PD 




We tested 35 patients with PD and 42 HC subjects. This sample 
was part of a more extended trial focusing on the effect of aerobic 
exercise on cognitive behavioral therapy in PD that was published 
elsewhere [45]. It was approved by the ethics committee at Chari- 
té – Universitätsmedizin Berlin (EA1/129/08) and registered at 




“ClinicalTrials.gov” (identifier: NCT01788800). All study proce-
dures were conducted in accordance with the Declaration of Hel-
sinki.
Patients were recruited through the Charité’s outpatient clinic 
for anxiety disorders. PD was diagnosed by a trained psychologist 
via the Mini-International Neuropsychiatric Interview [46]. HC 
subjects were recruited through advertisement in the clinic’s envi-
ronment. All participants provided written informed consent pri-
or to their participation. We included patients and HC aged be-
tween 18 and 70 years, with no history of head trauma or neuro-
logical disease. Further inclusion criteria for patients encompassed 
a diagnosis of PD according to the Diagnostic and Statistical Man-
ual of Mental Disease, 4th revision, DSM-IV [47], absence of phar-
macotherapy within the last 4 weeks as well as the absence of any 
other severe psychiatric diagnosis or acute suicidality. HC were 
included if they were free of any present psychiatric diagnosis and 
did not consume drugs or psychotropic medication. Anxiety 
symptom severity in both patients and HC was assessed using the 
Hamilton Anxiety Scale [HAMA, 48], the self-rating version of the 
Panic and Agoraphobia Scale [PAS, 49] and the Beck Anxiety In-
ventory [BAI, 50]. The Hamilton Depression Scale [HAMD-17, 
51] and the Beck Depression Inventory II [BDI-II, 52] were used 
to measure depressive symptoms.
Demographic and clinical characteristics of our sample are pre-
sented in Table 1. PD patients and HC did not differ significantly 
with regard to age, sex ratio and handedness. As expected, patients 
reported significantly more anxiety- and depression-related symp-
toms than control subjects. 
Auditory Stimulation
The participants were seated in a chair with a head rest in a 
sound-attenuated room. Auditory stimuli were presented binau-
rally through headphones. The participants were instructed to 
keep their eyes open and look at a fixation point on a screen. In 
total, 1,800 tone stimuli (80 dB SPL) were presented. Standard 
tones (80%) had a frequency of 1,000 Hz and duration of 90 ms 
(10 ms rise/fall time). In contrast, frequency deviant tones (10%) 
had a frequency of 1,200 Hz and duration deviant tones a dura-
tion of 50 ms (10 ms rise/fall time). Deviant tones were always 
followed by a standard tone. Intertrial intervals varied in a pseu-
dorandomized sequence between 350 and 650 ms (mean: 500 ± 
110 ms).
Electroencephalographic Data
EEG was carried out with 32 Ag/Ag-Cl electrodes according to 
the extended international 10/20 system using an electrode cap 
(EASYCAP GmbH, Herrsching, Germany). The ocular electrode 
was located on the outer canthus of the left eye and the ground elec-
trode on the forehead. Electrode impedances were below 10 kΩ. EEG 
was recorded with BrainAmp hardware (Brain Products GmbH, 
Munich, Germany) with a sampling rate of 250 Hz (high-pass filtered 
at 0.016 Hz) and referenced to electrode Cz. Offline MMN analysis 
was conducted with Brain Vision Analyzer 2.0 (Brain Products, Mu-
nich, Germany) and EEGlab Version v13.1.1 [53]. Artifacts were au-
tomatically corrected using the eeglab-plugins Artifact Subspace Re-
construction Version 0.13 [54] and Automatic Artifact Removal 
Version 1.3 [55] for short-term artifacts, e.g. ocular movements and 
electrocardiac artifacts. After filtering (high pass: 0.5 Hz, order 2; 50 
Hz notch filter; zero phase shift Butterworth IIR filter) and artifact 
rejection (100 µV), data were re-referenced to common average and 
30-Hz low-pass filtered (order 2). Data were segmented (–150 to 300 
ms), baseline corrected (–150 to 0 ms) and averaged per subject and 
stimulus condition. MMN were obtained by subtracting the wave-
forms elicited by standards from those elicited by deviants at Cz and 
Fz electrodes. MMN amplitudes were defined as the most negative 
peak from 170 to 270 ms (duration MMN) and 110 to 240 ms (fre-
quency MMN) according to the grand average. MMN were extracted 
as negative mean amplitude (10 ms around the peak).
Statistical Analysis
MMN amplitudes and latencies were analyzed with a repeated 
measurement multivariate analysis of covariance (MANCOVA) 






Sex, female 15.0 (43%) 16.0 (38%) χ2(1) = 0.18; p > 0.6
Right-handedness 32.0 (91%) 40.0 (95%) χ2(1) = 0.59; p > 0.7
Age, years 31.5 (6.9) 34.1 (9.8) t(75) = 1.30; p > 0.19
Age of onset, years 28.7 (7.8)
Duration of illness, months 42.1 (55.5)
Time of EEG 15.1 (3.2) 15.9 (2.8) t(75) = 1.217; p > 0.2
HAM-A 19.1 (9.3) 2.1 (2.8) t(39.06) = 10.41; p < 0.0001
BAI 18.1 (10.2) 1.7 (2.1) t(36.34) = 9.41; p < 0.0001
PAS 18.7 (8.9) 0.1 (0.3) t(34.1) = 12.31; p < 0.0001
HAMD-17 6.8 (4.5) 0.5 (0.9) t(36.07) = 8.31; p < 0.0001
BDI-II 12.0 (9.0) 1.6 (2.1) t(37.26) = 6.84; p < 0.0001
Values are presented as n (%) or means (standard deviations). HAM-A, Hamilton Anxiety Rating Scale; BAI, 
Beck Anxiety Inventory; PAS, Panic and Agoraphobia Scale; HAMD-17, Hamilton Rating Scale for Depression; 





with the between-subject factors sex and group (PD and control), 
as well as the within-subject factor electrode (Fz and Cz). Addi-
tionally, age was analyzed as covariate.
Correlations between the duration MMN and anxiety severity, 
as well as general somatic symptoms “HAMA-somatic anxiety 
subscore” (calculated as the sum of HAMA items 7–10 measuring 
general muscular somatic symptoms, general sensory somatic 
symptoms, cardiovascular symptoms and respiratory symptoms) 
were analyzed with Pearson correlations. An α-level of 0.05 indi-
cated significance in all analyses.
Results
MMN latencies and amplitudes at Cz and Fz elec-
trodes are given in Table 2. Additionally, evoked poten-
tials for the standard stimuli, the duration and frequency 
deviants are displayed in Figure 1.
Repeated measurement MANCOVA for MMN latency 
revealed no significant effect of the between-subject factor 
group (F(2, 72) = 0.39, p > 0.531) and of the between-sub-
ject factor sex (F(2, 72) = 0.262, p > 0.770). The within-
subject factor electrode (Fz, Cz; F(2, 72) = 0.242, p > 0.786) 
had no significant effect. There was a statistical trend for an 
effect of the covariate age (F(2, 72) = 2.850, p < 0.07).
Repeated measurement MANCOVA for MMN ampli-
tudes revealed a significant effect of the between-subject 
factor group (F(2, 72) = 3.863, p < 0.026), but not of the 
between-subject factor sex (F(2, 72) = 3.10, p > 0.73) and 
the within-subject factor electrode (Fz, Cz; F(2, 72) = 
1.782, p > 0.17) on MMN. The covariate age had no sta-
tistically significant impact on MMN (F(2, 72) = 1.134, 
p > 0.32). Post hoc ANCOVA showed a significant effect 
of the main factor diagnosis on duration MMN ampli-
tude (F(1, 73) = 7.32, p < 0.009) but not on frequency 
MMN amplitude (F(1, 73) = 0.76, p > 0.78).
The duration MMN amplitude difference remains sig-
nificant when patients with strong depressive symptoms 
(n = 3, as defined by a HAMD-17 score > 12) are excluded 
from analysis, (F(1, 70) = 6.401, p < 0.014). The significant 
differences for duration MMN amplitude remain also sig-
nificant under exclusion of all left-handed participants 
in the patient group (n = 3) and the HC group (n = 2) 
(F(1, 68) = 7.166, p < 0.01).
There were no statistically significant correlations be-
tween the duration MMN amplitude and severity of anxi-
ety symptoms (HAMA, r = 0.01, p > 0.9; PAS, r = –0.17, 
p > 0.3; BAI, r = –0.04, p > 0.8) or depressive symptoms 
(HAMD-17, r = –0.08, p > 0.6; BDI-II, r = 0.05, p > 0.7). 
However, the correlation between “HAMA-somatic anxi-
ety subscore” items 7–10 measuring somatic symptoms 
reached significance: r = 0.36, p = 0.04.
Discussion
This study investigated MMN as a preattentive indica-
tor for sensitivity to non-fear-related stimulus changes in 
unmedicated patients with PD. Most importantly, we 
found significant lower duration MMN amplitudes in the 
PD group compared to the HC group. No significant 
group difference was detected for frequency MMN am-
plitudes, as well as frequency MMN latencies and dura-
tion MMN latencies.
This finding agrees to some extent with a study con-
ducted by Tang et al. [44]. They investigated visual 
MMN related to negative and positive facial expressions 
in 12 PD patients and 17 HC and found significantly at-
tenuated visual MMN in response to both conditions in 
PD patients as compared to HC. The authors interpret 
this difference as a deficit in PD patients to automati-
cally detect facial emotions. In a synopsis, these results 
suggest an information-processing impairment in PD 
which can be found for both more complex stimuli 
(such as faces) and less complex stimuli (such as sounds). 
However, one other finding from the same study group 
indicates no difference in duration and frequency MMN 
amplitudes between PD patients and HC, but signifi-
cantly higher sound intensity and location MMN ampli-
tudes in PD patients as compared to HC [43]. Apart 
from the small sample size of 15 PD patients in their 
study, one potential explanation of these divergent re-
sults might be the use of a different paradigm including 
five different deviants in the study by Chang et al. [43]. 
Table 2. MMN latency (ms) and amplitude (µV) for panic disorder 





mean SD mean SD
Latency, ms
Cz frequency 175 37 167 38
Fz frequency 178 31 179 37
Cz duration 221 23 225 22
Fz duration 222 26 224 25
Amplitude, µV
Cz frequency –0.95 0.59 –0.97 0.71
Fz frequency –1.37 0.86 –1.4 0.93
Cz duration –0.64 0.44 –0.92 0.63
Fz duration –0.82 0.56 –1.17 0.79
Given are means and standard deviations.




Possibly, this paradigm which includes a broader variety 
of stimuli simulates a rather stimulus-rich and therefore 
potentially more fear-related environment than the use 
of a more reduced paradigm such as applied in the pres-
ent study.
Considering these aspects, our results may support 
the notion of reduced preattentive sensitivity to non-
fear-related stimulus changes in patients with PD. 
These results could potentially be explained by dis-
turbed signal-to-noise discrimination in PD [17]. More 
precisely, PD patients display increased processing of 
stimuli that are either fear-related or erroneously cate-
gorized as fear-relevant and decreased information 
processing of remaining stimuli. Hence, reduced dura-
tion MMN amplitudes found in this study seem to un-
derpin neurocognitive processes that are attenuated in 
PD patients, most likely due to the limited nature of 
cognitive resources. This interpretation is in line with 
prominent theoretical models of anxiety stating that 
anxiety leads to a reduced attention focus to fear-unre-
lated stimuli [56].
The finding of reduced duration but not frequency 
MMN amplitudes in PD patients might be explained by 
different aspects. One explanation for this finding 
might be that processing of sound duration deviants is 
affected to a larger degree than the processing of sound 
frequency deviants in PD patients. This explanation is 
supported by studies showing divergent deficits in du-
ration and frequency MMN amplitudes in other psy-
chiatric conditions [57, 58], likely due to differences in 
the underlying neuronal networks involved in preat-
tentive deviant sound processing. While frequency de-
viants seem to be processed in auditory-temporal brain 
areas, duration deviant processing seems to involve 
further key brain areas forming greater and more dis-
tributed networks [59]. Hence, normal frequency but 
disturbed duration MMN amplitudes in PD, as seen in 
our study, may indicate more complex disturbed net-
work activity than simple auditory-temporal brain dys-
function in preattentive automatic information pro-
cessing. One further explanation might be that dura-
tion deviants likely have a larger reliability than 
frequency deviants [60] and therefore are more sensi-
tive to group differences.
We found no correlations between duration MMN 
and severity of PD in our sample. This is in line with the 
trial of Tang et al. [44] who did not detect an association 
between MMN amplitude and symptom severity either. 
In contrast, Chang et al. [43] found an association be-
tween MMN amplitude and symptom severity as in-
dexed by the panic disorder severity scale [61]. This di-
vergent finding is potentially due to the use of a more 
complex design in Chang and colleagues’ study, simu-
lating a rather stimulus-rich environment that is poten-
tially more closely related to an increased level of stim-
ulus perception in panic attacks. Yet, in the present 
study, the correlation between a HAMA subscore cal-
culated for somatic symptoms and duration MMN am-
plitude reached significance. While this finding needs 
to be interpreted cautiously, it hints at the possibility 
that an increased perception of somatic symptoms is 
associated with fewer cognitive resources directed at 
preattentive processing of non-fear-related stimuli. As 
increased body vigilance has been repeatedly found in 
PD patients [8], this interpretation is in line with prom-
inent theoretical models of anxiety stating that anxiety 
leads to a reduced attention focus to fear-unrelated 
stimuli [56].
As a limitation of our study, it needs to be noted that 
no patients with comorbidities and medication were in-
cluded in this study. While this exclusion increases in-
ternal validity, however, it may reduce clinical represen-
tativeness of the sample. Additionally, there was no 
measure included for body vigilance. A strength of the 
present study is the relatively large sample size. Com-
pared to former studies addressing this topic [43, 44], we 
included more than twice as many patients and HC. 
This enhances both the validity and the generalizability 
of our results.
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